The global burden of HIV
- PMID: 38387533
- DOI: 10.1016/j.clindermatol.2024.02.001
The global burden of HIV
Abstract
The global burden of HIV remains a formidable challenge, affecting millions. Despite significant progress in understanding, treatment, and prevention , HIV/AIDS continues to exert a substantial impact on personal and public health, particularly in sub-Saharan Africa, where the prevalence is highest. HIV not only poses a direct threat to the well-being of individuals but also contributes to social and economic disparities. Approximately 38 million people worldwide are living with HIV, with millions unaware of their status. Stigma and discrimination still hinder testing, starting and staying on treatment. Access to antiretroviral therapy has improved, yet disparities persist, with marginalized communities often facing barriers to essential health care services. Efforts to reduce new HIV infections and transmission include comprehensive prevention strategies, education, and increased access to testing and treatment. Addressing social determinants, reducing stigma, and ensuring equitable access to health care remain crucial to reach the ambitious goal of ending AIDS by 2030.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Anton Pozniak reports receipt of grants/research support and honoraria or consultation fees from Janssen, Merck, Viiv, and Gilead. Sashini Payagala reports no conflicts of interest.
Similar articles
-
Partial waivers: PEPFAR's 2025 funding suspension and the looming HIV/AIDS catastrophe in Sub-Saharan Africa.Retrovirology. 2025 Mar 31;22(1):5. doi: 10.1186/s12977-025-00657-2. Retrovirology. 2025. PMID: 40165175 Free PMC article.
-
Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa.J Int AIDS Soc. 2011 Jul 6;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1758-2652-14-S1-S1. J Int AIDS Soc. 2011. PMID: 21967757 Free PMC article.
-
[Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].Sante. 2010 Apr-Jun;20(2):116-24. doi: 10.1684/san.2010.0185. Epub 2010 Aug 5. Sante. 2010. PMID: 20685643 French.
-
HIV/AIDS in sub-Saharan Africa.Dermatol Clin. 2006 Oct;24(4):421-9, v. doi: 10.1016/j.det.2006.06.003. Dermatol Clin. 2006. PMID: 17010772 Review.
-
HIV/AIDS in Sub-Saharan Africa.Croat Med J. 2004 Aug;45(4):402-14. Croat Med J. 2004. PMID: 15311412 Review.
Cited by
-
Method for modelling the number of HIV and AIDS cases using least square spline Biresponse nonparametric negative binomial regression.MethodsX. 2025 Apr 25;14:103336. doi: 10.1016/j.mex.2025.103336. eCollection 2025 Jun. MethodsX. 2025. PMID: 40395932 Free PMC article.
-
Pharmacokinetics of islatravir in participants with moderate hepatic impairment.Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0155324. doi: 10.1128/aac.01553-24. Epub 2025 Mar 5. Antimicrob Agents Chemother. 2025. PMID: 40042304 Free PMC article. Clinical Trial.
-
Analysis of risk factors of social frailty in older adults living with HIV/AIDS.Sci Rep. 2025 Apr 14;15(1):12769. doi: 10.1038/s41598-025-97466-6. Sci Rep. 2025. PMID: 40229403 Free PMC article.
-
Comparison of dried blood spot (DBS) and plasma HIV-1 viral load measurements using Roche COBAS AmpliPrep/COBAS TaqMan assay, Northwest Ethiopia.Virol J. 2025 May 15;22(1):145. doi: 10.1186/s12985-025-02762-2. Virol J. 2025. PMID: 40375258 Free PMC article.
-
High prevalence of late presentation with advanced HIV disease and its predictors among newly diagnosed patients in Kumasi, Ghana.BMC Infect Dis. 2024 Jul 31;24(1):764. doi: 10.1186/s12879-024-09682-6. BMC Infect Dis. 2024. PMID: 39085822 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical